Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Incyte Corp (NASDAQ:INCY)

96.58
Delayed Data
As of Dec 08
 +1.75 / +1.85%
Today’s Change
92.91
Today|||52-Week Range
153.15
-3.68%
Year-to-Date

Today’s Trading

Previous close94.83
Today’s open95.26
Day’s range95.26 - 97.91
Volume1,339,633
Average volume (3 months)1,635,881
Market cap$20.4B
Dividend yield--
Data as of 4:00pm ET, 12/08/2017

Growth & Valuation

Earnings growth (last year)+1,700.00%
Earnings growth (this year)-330.50%
Earnings growth (next 5 years)+75.95%
Revenue growth (last year)+46.70%
P/E ratioNM
Price/Sales17.60
Price/Book43.48

Competitors

 Today’s
change
Today’s
% change
ZTSZoetis Inc+0.24+0.34%
ALXNAlexion Pharmaceutic...+7.68+7.19%
BAXBaxter International...+0.53+0.83%
MYLMylan NV+1.30+3.48%
Data as of 4:15pm ET, 12/08/2017

Financials

Next reporting dateFebruary 14, 2018
EPS forecast (this quarter)-$0.53
Annual revenue (last year)$1.1B
Annual profit (last year)$104.2M
Net profit margin9.43%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Hervé Hoppenot
Chief Financial Officer &
Executive Vice President
David W. Gryska
Corporate headquarters
Wilmington, Delaware

Forecasts